Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION USP

Last updated on 2020-03-27 History
Report ID 106842
Drug Identification Number 02258218
Brand name IRINOTECAN HYDROCHLORIDE INJECTION USP
Common or Proper name Irinotecan Hydrochloride Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 25mL vial
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-02-21
Actual start date
Estimated end date
Actual end date 2020-03-26
Shortage status Resolved
Updated date 2020-03-27
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-03-27 English Compare
v5 2020-03-26 French Compare
v4 2020-03-26 English Compare
v3 2020-02-22 English Compare
v2 2020-02-21 French Compare
v1 2020-02-21 English Compare